«Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway», NJPS, вип. 40, вип. 2, с. 251–262, Груд 2025, doi: 10.54548/.